Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience
- 30 September 2013
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 166 (3), 597-603
- https://doi.org/10.1016/j.ahj.2013.06.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intoleranceJournal of Clinical Lipidology, 2011
- Statin myopathy: A common dilemma not reflected in clinical trialsCleveland Clinic Journal of Medicine, 2011
- Prevalence of Musculoskeletal Pain and Statin UseJournal of General Internal Medicine, 2008
- Efficacy of Rosuvastatin (5 mg and 10 mg) Twice a Week in Patients Intolerant to Daily StatinsThe American Journal of Cardiology, 2008
- Effectiveness of Ezetimibe Alone or in Combination With Twice a Week Atorvastatin (10 mg) for Statin Intolerant High-Risk PatientsThe American Journal of Cardiology, 2008
- Risks Associated With Statin TherapyCirculation, 2006
- Alternate-day dosing of atorvastatin: effects in treating type 2 diabetic patients with dyslipidaemiaActa Diabetologica, 2006
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCurrent Opinion in Cardiology, 2006
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesJournal of the American College of Cardiology, 2004
- Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS)American Heart Journal, 2002